Systemic rheumatoid vasculitis: a review

MS Genta, RM Genta, C Gabay - Seminars in arthritis and rheumatism, 2006 - Elsevier
OBJECTIVES: To review the most recent information on the incidence, clinical course,
pathology, pathogenesis, diagnosis, and treatment of rheumatoid vasculitis (RV), including …

Rheumatoid vasculitis in 2023: changes and challenges since the biologics era

P Mertz, C Wollenschlaeger, F Chasset, A Dima… - Autoimmunity …, 2023 - Elsevier
Background Significant changes in the epidemiology and natural history of rheumatoid
vasculitis (RV) have occurred with the introduction of biological therapies such as TNF …

Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

MR Weiser, JP Williams, FD Moore Jr… - The Journal of …, 1996 - rupress.org
Reperfusion of ischemic tissue induces an acute inflammatory response that can result in
necrosis and irreversible cell injury to both local vascular endothelium and parenchyma. To …

Intestinal reperfusion injury is mediated by IgM and complement

JP Williams, TTV Pechet, MR Weiser… - Journal of applied …, 1999 - journals.physiology.org
Intestinal ischemia-reperfusion injury is dependent on complement. This study examines the
role of the alternative and classic pathways of complement and IgM in a murine model of …

Anti-endothelial cell antibodies in systemic sclerosis

C Mihai, JWC Tervaert - Annals of the Rheumatic Diseases, 2010 - ard.bmj.com
Anti-endothelial cell antibodies (AECA) are a heterogeneous class of antibodies whose role
in the pathogenesis of autoimmune diseases with vascular involvement has been …

Antiendothelial cell antibodies in vasculitis and connective tissue disease

C Belizna, A Duijvestijn, M Hamidou… - Annals of the rheumatic …, 2006 - ard.bmj.com
Antiendothelial cell antibodies (AECA) are a heterogeneous family of antibodies reacting
with endothelial cell antigens. These antibodies are found in various diseases and …

Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis

E Arosio, S De Marchi, A Rigoni, M Prior… - Journal of …, 2007 - journals.lww.com
Objectives Cardiovascular disease is the major cause of mortality in patients with
rheumatoid arthritis. This work studied the presence of impaired forearm haemodynamics …

Antiendothelial cell antibodies in systemic lupus erythematosus

Y Renaudineau, C Dugué, M Dueymes, P Youinou - Autoimmunity reviews, 2002 - Elsevier
Sera from patients with systemic lupus erythematosus have been reported to contain IgM
and/or IgG binding to endothelial cells (EC), ie anti-EC antibodies (AECA). Similar …

Specificity, pathogenecity, and clinical value of antiendothelialcell antibodies

C Belizna, JWC Tervaert - Seminars in arthritis and rheumatism, 1997 - Elsevier
OBJECTIVE:: To characterize the putative target antigens for antiendothelial cell antibodies
(AECA), the possible pathophysiological role of AECA, and the clinical value of these …

Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.

N Tamura, S Kobayashi, K Kato, H Bando… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: To determine the levels of soluble CD154 (sCD154) in the plasma of patients
with rheumatoid arthritis (RA) and rheumatoid vasculitis (RV). and to examine the …